Skip to main content

Table 8 Characterization of UTI isolates

From: An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study

Strain Resistance profile Phylo-group PMQR genes QRDR mutations β-lactamase-resistance-genes Other resistant genes Integron
∆GyrA ∆ParC
UEc 11 AMP, SXT B2   NA NA bla TEM ant(3″)-Ia (aadA1), aph3 (strA), dhfrI, sulII, tet(B) Class 2 integron
UEc 22 AMP, SAM, AMC, CFZ, SXT, CIP, LEV, NOR B2   S83 → L
D87 → N
S80 → I
T66 → N
bla TEM tet(B)  
UEc 23 AMP, SAM, CFZ, CTZ, CAZ, CRO, FEP, SXT, CIP, LEV F aac(6′)-Ib-cr NA NA   aac(3)-IIa (aacC2) Class 1 integron
UEc 27 GEN, AMP, SAM, AMC, SXT, CIP, LEV B2   S83 → L
D87 → N
S80 → I
E84 → V
bla PSE-1 sulI, tet(A)  
UEc 30 GEN, SAM, AMC, SXT B2   NA NA bla OXA-1 ant(3″)-Ia (aadA1), tet(A), tet(30), tet®, sulI Class 1 integron
UEc 58 AMP, SXT, CIP, LEV B2   S83 → L
D87 → N
G114 → S
S80 → I bla TEM dhfrVII, sulII, tet(B), aph3 (strA), mphA  
UEc 65 AMP, CFZ, CAZ, CRO, FEP, CIP, LEV D   S83 → L
D87 → N
G114 → S
S80 → I bla CTX-M-15
bla TEM
aac(3)-IIa (aacC2), dhfrVII, mphA, sulI, tet(B) Class 1 integron
UEc 69 AMP, SXT, NIT B2 qnrA NA NA bla TEM sulII  
UEc 75 AMK, GEN, AMP, SAM, AMC, TZP, CFZ, CTX, CRO, FEPCIP, LEV, NOR B2 qnrA S83 → L
D87 → N
S80 → I
T66 → Y
blaOXY/K1, blaTEM aac(3)-IIa (aacC2), aph(3′)-Ia (aphA1), aph(3′)-IIa (aphA2), aph3 (strA), sulI, sulII, tet(A), tet(B)  
UEc 76 CFZ, CAZ, CRO, FEP, CIP, LEV B2   S83 → L
D87 → N
S80 → I
T66 → Y
E84 → V
bla CTX-M-15
bla OXA-1
tet(A), tet(30)  
UEc 84 GEN, TOB, AMP, SAM, TZP, CFZ, CTX, CAZ, CRO, FEP, SXT, CIP, LEV D aac(6′)-Ib-cr S83 → L
D87 → N
S80 → I blaCTX-M-15, blaOXA-1
bla TEM
bla PSE-4
tet(30), mphA  
UEc 99 AMP, SXT B2 qnrA None None blaCTX-M-12,
blaOXA-9, blaTEM
aac(3)-IV, aac(3)-IIa (aacC2), aph3 (strA), catI, sulI, sulII Class 1 integron
UEc 102 AMP, CFZ, CAZ, CRO, FEP, SXT, CIP, LEV B2   S83 → L
D87 → N
G114 → S
S80 → I bla TEM aph(3′)-Ia (aphA1), sulII  
UEc 104 AMP, SXT D qnrA, aac(6′)-Ib-cr NA NA blaCMY-2,
blaCTX-M-12, blaOXA-1
aac(3)-IIa (aacC2), sulI, tet(B), mphA Class 1 integron
UEc 107   F   NA NA    
UEc 108 AMP D qnrA NA NA bla TEM sulI Class 1 integron
UEc 109 AMP, SAM D aac(6′)-Ib-cr NA NA bla TEM sulII  
UEc 110 GEN, TOB, AMP, SAM, CTX, SXT, CIP, NIT B2   NA NA   aac(3)-IIa (aacC2), tet(B) Class 1 integron
  1. AMK Amikacin, GEN gentamicin, TOB tobramycin, NET netilmicin, AMP ampicillin, SAM ampicillin–sulbactam, AMC amoxicillin–clavulanic acid, TZP piperacillin–tazobactam, CFZ cefazolin, CTX cefotaxime, CAZ ceftazidime, CRO ceftriaxone, FEP cefepime; SXT trimethoprim–sulfamethoxazole, CIP ciprofloxacin, LEV levofloxacin, NOR norfloxacin, NIT nitrofurantoin, ETP ertapenem, IPM imipenem, PMQR plasmid-mediated quinolone resistance genes, QRDR quinolone resistance-determining region, NA not analyzed